These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 30255479)

  • 1. Asymptomatic and normocalcemic hyperparathyroidism, the silent attack: a combo-endocrinology overview.
    Anastasilakis DA; Makras P; Polyzos SA; Anastasilakis AD;
    Hormones (Athens); 2019 Mar; 18(1):65-70. PubMed ID: 30255479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An overview of normocalcemic primary hyperparathyroidism.
    Pawlowska M; Cusano NE
    Curr Opin Endocrinol Diabetes Obes; 2015 Dec; 22(6):413-21. PubMed ID: 26512768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MECHANISMS IN ENDOCRINOLOGY: Kidney involvement in patients with primary hyperparathyroidism: an update on clinical and molecular aspects.
    Verdelli C; Corbetta S
    Eur J Endocrinol; 2017 Jan; 176(1):R39-R52. PubMed ID: 27601015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asymptomatic and mild primary hyperparathyroidism.
    Macfarlane DP; Yu N; Leese GP
    Ann Endocrinol (Paris); 2015 May; 76(2):120-7. PubMed ID: 25882891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-familial primary hyperparathyroidism.
    Akerström G
    Semin Surg Oncol; 1997; 13(2):104-13. PubMed ID: 9088066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The diagnosis and management of asymptomatic primary hyperparathyroidism.
    Silverberg SJ; Bilezikian JP
    Nat Clin Pract Endocrinol Metab; 2006 Sep; 2(9):494-503. PubMed ID: 16957763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular risk factors and arterial rigidity are similar in asymptomatic normocalcemic and hypercalcemic primary hyperparathyroidism.
    Tordjman KM; Yaron M; Izkhakov E; Osher E; Shenkerman G; Marcus-Perlman Y; Stern N
    Eur J Endocrinol; 2010 May; 162(5):925-33. PubMed ID: 20421337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asymptomatic primary hyperparathyroidism: a medical perspective.
    Silverberg SJ; Bilezikian JP
    Surg Clin North Am; 2004 Jun; 84(3):787-801. PubMed ID: 15145235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Primary hyperparathyroidism - new clinical forms of the disease].
    Zajíčková K
    Vnitr Lek; 2017; 63(9):604-608. PubMed ID: 29120658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary hyperparathyroidism--is mild disease worth treating?
    Gittoes NJ; Cooper MS
    Clin Med (Lond); 2010 Feb; 10(1):45-9. PubMed ID: 20408307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical management of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop.
    Khan A; Grey A; Shoback D
    J Clin Endocrinol Metab; 2009 Feb; 94(2):373-81. PubMed ID: 19193912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop.
    Silverberg SJ; Clarke BL; Peacock M; Bandeira F; Boutroy S; Cusano NE; Dempster D; Lewiecki EM; Liu JM; Minisola S; Rejnmark L; Silva BC; Walker MD; Bilezikian JP
    J Clin Endocrinol Metab; 2014 Oct; 99(10):3580-94. PubMed ID: 25162667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Primary hyperparathyroidism: new concepts, new recommendations].
    Crouzeix G; Kerlan V
    Ann Endocrinol (Paris); 2014 Oct; 75 Suppl 1():S21-36. PubMed ID: 25617920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non classical complications of primary hyperparathyroidism.
    Chiodini I; Cairoli E; Palmieri S; Pepe J; Walker MD
    Best Pract Res Clin Endocrinol Metab; 2018 Dec; 32(6):805-820. PubMed ID: 30665548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular risk and metabolic syndrome in primary hyperparathyroidism and their correlation to different clinical forms.
    Procopio M; Barale M; Bertaina S; Sigrist S; Mazzetti R; Loiacono M; Mengozzi G; Ghigo E; Maccario M
    Endocrine; 2014 Nov; 47(2):581-9. PubMed ID: 24287796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Normocalcemic Primary Hyperparathyroidism: A Comparison with the Hypercalcemic Form in a Tertiary Referral Population.
    Pierreux J; Bravenboer B
    Horm Metab Res; 2018 Nov; 50(11):797-802. PubMed ID: 30396209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical and Skeletal Outcomes of Parathyroidectomy for Normocalcemic (Incipient) Primary Hyperparathyroidism.
    Sho S; Kuo EJ; Chen AC; Li N; Yeh MW; Livhits MJ
    Ann Surg Oncol; 2019 Feb; 26(2):539-546. PubMed ID: 30406488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Renal function in primary hyperparathyroidism].
    Borretta G; Gianotti L; Cesario F; Borretta V; Tassone F
    G Ital Nefrol; 2010; 27 Suppl 50():S91-5. PubMed ID: 20922703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Normocalcemic primary hyperparathyroidism].
    Spivacow FR; Sapag Durán A; Zanchetta MB
    Medicina (B Aires); 2014; 74(6):457-61. PubMed ID: 25555006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nontraditional manifestations of primary hyperparathyroidism.
    Walker MD; Rubin M; Silverberg SJ
    J Clin Densitom; 2013; 16(1):40-7. PubMed ID: 23374740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.